SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-164130
Filing Date
2018-05-15
Accepted
2018-05-15 16:18:32
Documents
7
Effectiveness Date
2018-05-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d562157ddefa14a.htm DEFA14A 35168
2 GRAPHIC g562157img1.jpg GRAPHIC 3910
3 GRAPHIC g562157img2.jpg GRAPHIC 1748
4 GRAPHIC g562157img3.jpg GRAPHIC 3707
5 GRAPHIC g562157img4.jpg GRAPHIC 1751
6 GRAPHIC g562157img5.jpg GRAPHIC 1754
7 GRAPHIC g562157img6.jpg GRAPHIC 1746
  Complete submission text file 0001193125-18-164130.txt   57330
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36483 | Film No.: 18836758
SIC: 8071 Services-Medical Laboratories